A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

PHASE3CompletedINTERVENTIONAL

Enrollment

377

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2012

Conditions

Diabetes MellitusMacular Edema

Interventions

DRUG

Ranibizumab

Sterile solution for intravitreal injection.

DRUG

Sham injection